PET/CT is performed using different radiopharmaceuticals, depending on the organ under study:
PET/CT with glucose (18F-FDG) – for lung cancer, tumors of unknown localization, lymphomas, breast cancer, colorectal cancer, malignant melanoma of the skin, gynecological oncological diseases (ovarian cancer, cervical cancer), esophageal cancer, testicular cancer.
PAT/CT with methionine – for diseases of the brain.
PET / CT with choline (11C) – for diseases of the prostate gland, parathyroid adenoma.
What problem does PET/CT solve?
Diagnosis of neoplasms at the earliest stages.
Assessment of the prevalence of the tumor process.
Evaluation of the effectiveness of the treatment.
Assessment of the state of organs and systems.
Detection of metastases.
Advantages of PET/CT:
Obtaining morphological and functional information about the object under study at the same time.
It allows not only to detect the primary tumor, but also to detect metastases to the lymph nodes, other organs and tissues.
Enables the doctor to plan further treatment in a timely and correct manner (or change it).
High information content, high accuracy of the study, the ability to diagnose those tumor foci that other research methods cannot visualize.
The physiology of research.
Absence of injury.
Speed of research.